|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.04 CAD | +2.97% |
|
+0.97% | +15.56% |
ZYUS Life Sciences Corporation reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was CAD 0.114 million compared to CAD 0.078 million a year ago. Net loss was CAD 3.34 million compared to CAD 4.84 million a year ago.
Basic loss per share from continuing operations was CAD 0.05. Diluted loss per share from continuing operations was CAD 0.05.
| 1st Jan change | Capi. | |
|---|---|---|
| +15.56% | 53.93M | |
| +26.76% | 46.56B | |
| +45.04% | 41.67B | |
| -0.35% | 41.16B | |
| +34.74% | 32.4B | |
| +20.91% | 28.18B | |
| -6.35% | 28.1B | |
| +49.52% | 14.52B | |
| +47.01% | 13.74B | |
| +1.53% | 12.17B |
ZYUS LIFE SCIENCES CORPORATION 
